No Picture
San Diego Biotech Jobs

Scientist 1

What if the work you did every day could impact the lives of people you know? Or all… Click here to view original post

No Picture
News

L?kahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™

RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–L?kahi Therapeutics™ partners with Pepperdine E2B™ to expand ai² Pipeline™, engaging MBA students in evaluating biopharmaceutical assets. Click here to view original post Click Here to Publish/Feature Your Company […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Alume Biosciences Announces U.S. FDA Breakthrough Therapy Designation Granted for Bevonescein, a First-in-Class adjunct in the real-time intraoperative visualization of nerves during head and neck surgical procedures in adults

SAN DIEGO–(BUSINESS WIRE)–Alume Biosciences Announces U.S. FDA Breakthrough Therapy Designation Granted for Bevonescein Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ACROBiosystems Introduces CHO-Direct and ACRO AIx to Accelerate AI-driven Drug Discovery

SAN DIEGO, Sept. 24, 2026 /PRNewswire/ — Recently, ACROBiosystems unveiled its latest innovation portfolio—ACRO AIx, CHO-Direct and GlobalLifeShip cross border supply chain to respond the demand of AIDD era. As artificial intelligence becomes increasingly integrated […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

BioTools Innovator Announces the 2026 Finalists

LOS ANGELES–(BUSINESS WIRE)– #BTI–BioTools Innovator names 4 finalists (Caravel, eGlint, Pando Bioscience, QuantumCyte) to compete for $250K at Oct 14 Capstone in San Diego. Click here to view original post Click Here to Publish/Feature Your […]

No Picture
News

Primmune Therapeutics Announces Enrollment Milestone in Phase 2 INFLECTION–003 Study of Polvitolimod HCl in Neoadjuvant Melanoma

SAN DIEGO, Sept. 24, 2026 (GLOBE NEWSWIRE) — Primmune Therapeutics, a biotech company harnessing the power of the innate and adaptive immune system, today announced the enrollment of the second patient in its Phase 2 […]

News

Viking Therapeutics Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes

SAN DIEGO, Sept. 24, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the pricing of its concurrent […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the treatment of hallucinations and delusions […]

No Picture
News

MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)

LA JOLLA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today […]

No Picture
San Diego Biotech Jobs

Scientist 2

What if the work you did every day could impact the lives of people you know? Or all… Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

L?kahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform

RUTHERFORD, N.J. & LA JOLLA, Calif. & LOS ANGELES–(BUSINESS WIRE)–L?kahi Therapeutics™ Advances its Proprietary ai² PIPELINE Process from Internal Asset Engine to Revenue-Generating Platform. Click here to view original post Click Here to Publish/Feature Your […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension

SAN DIEGO–(BUSINESS WIRE)—- $GOSS–Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension […]

No Picture
News

Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform

SAN DIEGO–(BUSINESS WIRE)—- $ARCT #65Roses–Arcturus Therapeutics Holdings Inc. (the “Company,” “Arcturus,” Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory therapeutics, today announced encouraging interim Phase 2 results from […]

News

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

SAN DIEGO, Sept. 23, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its intention to offer, subject […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
Industry News

Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models

Genialis and Inventia Life Sciences agreed to work together to improve how new treatments for pancreatic cancer are tested and matched to the patients most likely to benefit. The companies will combine Genialis’ AI-powered patient […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies

SAN DIEGO, Sept. 23, 2026 (GLOBE NEWSWIRE) — Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed test (LDTs), today announced expansion of optical genome mapping (OGM) based […]

News

Tempo Therapeutics Awarded $2.25 Million NIH SBIR Grant to Advance MAP™ Technology for Complex Wound Healing

Novel synthetic biomaterial is designed to support volumetric tissue regeneration while minimizing inflammatory foreign-body response SAN DIEGO, Sept. 23, 2026 /PRNewswire/ — Tempo Therapeutics, Inc. (“Tempo”), a clinical-stage regenerative medicine company pioneering synthetic… Click here […]